SCHEMBL21099458

SCHEMBL21099458

CNCC1CCCCCCCC(C)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.44
ACHE P22303 1/20 0.41
ADH1B P00325 1/20 0.39
ADH1C P00326 1/20 0.39
ADH1A P07327 1/20 0.39
ADH4 P08319 1/20 0.39
ADH7 P40394 1/20 0.39
EPHX1 P07099 3/20 0.35
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MMP9 P14780 1/20 0.33
MMP8 P22894 1/20 0.33
CA9 Q16790 1/20 0.33
CYP2D6 P10635 1/20 0.32
CARM1 Q86X55 1/20 0.32
PRMT6 Q96LA8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19261996 0.93 SIGMAR1 (0.36) SIGMAR1ACHEADH1BADH1CADH1A
SCHEMBL22047967 0.93 SIGMAR1 (0.45) SIGMAR1ACHEADH1BADH1CADH1A
SCHEMBL22704489 0.93 SIGMAR1 (0.43) SIGMAR1ACHEADH1BADH1CADH1A
SCHEMBL22704480 0.91 SIGMAR1 (0.42) SIGMAR1ACHEADH1BADH1CADH1A
SCHEMBL24645750 0.91 SIGMAR1 (0.42) SIGMAR1ACHEADH1BADH1CADH1A
SCHEMBL12018277 0.89 SIGMAR1 (0.39) SIGMAR1ACHEADH1BADH1CADH1A
SCHEMBL13638469 0.89 CARM1 (0.38) SIGMAR1CARM1PRMT6PRMT1PRMT8
SCHEMBL8275755 0.89 CARM1 (0.38) SIGMAR1CARM1PRMT6PRMT1PRMT8
SCHEMBL16727917 0.89 CARM1 (0.38) SIGMAR1CARM1PRMT6PRMT1PRMT8
SCHEMBL21106601 0.86 SIGMAR1 (0.54) SIGMAR1ADH1BADH1CADH1AADH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019113542-A1 HETEROCYCLE SUBSTITUTED PYRIDINE DERIVATIVE ANTIFUNGAL AGENTS AMPLYX PHARMACEUTICALS, INC. (US) 2019-06-13 WO disclosed